Severe Cellular Immunodeficiency Triggered by the CDK4/6 Inhibitor Palbociclib

Detalles Bibliográficos
Autores principales: Guillaume, Zoé, Medioni, Jacques, Lillo-Lelouet, Agnes, Marret, Grégoire, Oudard, Stéphane, Simonaggio, Audrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102668/
https://www.ncbi.nlm.nih.gov/pubmed/32088132
http://dx.doi.org/10.1016/j.clbc.2020.01.009
_version_ 1783511883293130752
author Guillaume, Zoé
Medioni, Jacques
Lillo-Lelouet, Agnes
Marret, Grégoire
Oudard, Stéphane
Simonaggio, Audrey
author_facet Guillaume, Zoé
Medioni, Jacques
Lillo-Lelouet, Agnes
Marret, Grégoire
Oudard, Stéphane
Simonaggio, Audrey
author_sort Guillaume, Zoé
collection PubMed
description
format Online
Article
Text
id pubmed-7102668
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-71026682020-03-31 Severe Cellular Immunodeficiency Triggered by the CDK4/6 Inhibitor Palbociclib Guillaume, Zoé Medioni, Jacques Lillo-Lelouet, Agnes Marret, Grégoire Oudard, Stéphane Simonaggio, Audrey Clin Breast Cancer Case Report Elsevier Inc. 2020-04 2020-02-20 /pmc/articles/PMC7102668/ /pubmed/32088132 http://dx.doi.org/10.1016/j.clbc.2020.01.009 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Case Report
Guillaume, Zoé
Medioni, Jacques
Lillo-Lelouet, Agnes
Marret, Grégoire
Oudard, Stéphane
Simonaggio, Audrey
Severe Cellular Immunodeficiency Triggered by the CDK4/6 Inhibitor Palbociclib
title Severe Cellular Immunodeficiency Triggered by the CDK4/6 Inhibitor Palbociclib
title_full Severe Cellular Immunodeficiency Triggered by the CDK4/6 Inhibitor Palbociclib
title_fullStr Severe Cellular Immunodeficiency Triggered by the CDK4/6 Inhibitor Palbociclib
title_full_unstemmed Severe Cellular Immunodeficiency Triggered by the CDK4/6 Inhibitor Palbociclib
title_short Severe Cellular Immunodeficiency Triggered by the CDK4/6 Inhibitor Palbociclib
title_sort severe cellular immunodeficiency triggered by the cdk4/6 inhibitor palbociclib
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102668/
https://www.ncbi.nlm.nih.gov/pubmed/32088132
http://dx.doi.org/10.1016/j.clbc.2020.01.009
work_keys_str_mv AT guillaumezoe severecellularimmunodeficiencytriggeredbythecdk46inhibitorpalbociclib
AT medionijacques severecellularimmunodeficiencytriggeredbythecdk46inhibitorpalbociclib
AT lillolelouetagnes severecellularimmunodeficiencytriggeredbythecdk46inhibitorpalbociclib
AT marretgregoire severecellularimmunodeficiencytriggeredbythecdk46inhibitorpalbociclib
AT oudardstephane severecellularimmunodeficiencytriggeredbythecdk46inhibitorpalbociclib
AT simonaggioaudrey severecellularimmunodeficiencytriggeredbythecdk46inhibitorpalbociclib

Ejemplares similares